Disc Medicine recently reported that it is well-capitalized with over US$800.00 million in cash, has submitted a New Drug Application for bitopertin seeking accelerated FDA review, and released ...
Source LinkDisc Medicine recently reported that it is well-capitalized with over US$800.00 million in cash, has submitted a New Drug Application for bitopertin seeking accelerated FDA review, and released ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.